Renal physiology Flashcards
Substances absorbed in PCT
60% of Na
HCO3 reabsorption
All glucose and amino acids
Solute excretion : cations: Cr, Li, cimetidine
anions: urate, diuretics, radiocontrast media, penicillin., cephalosporin
Site of action of loop diuretics
TAL of LH - Na-k-2CL transporter
25-30% Na reabsorption
Site of absorption of Ca and Mg -paracellular diffusion (claudin 16 gene)
Mutation of claudin 16 ->hypomagnesemia, nephrocalcinosis
Bartter syndrome features
AR, normotensive
Hypokalemic metabolic alkalosis, hypercalciuria+/-hypomagnesemia, sodium loss
Increased renin and aldosterone due to low Na
Bartter syndrome genetics
Type 1 -NKCC2 -neonatal Type 2-ROMK -neonatal Type 3-CLCNKB -classic Type 4 -BSND - neonatal with deafness Type 5 -CLCNKB, CLCNKA -neonatal with deafness
All present with hyokalemic metabolic alkalosis
Site of action of thiazides, indapamide, metalazone
Distal tubule
NKCC1 channel - Na-Cl transporter
Also absorption of Ca and Mg at DT
Thiazide -cause increase Ca absorption, hypocalciuria -used to treat stones
Absorption of Mg and Ca in DCT
Mg -TRPM6/M7 Channel
Inhibited by CNI esp Tacrolimus
Ca - TRPV5 channel,upregulated by PTH
Genetics in Gitelman syndrome
Autosomal recessive , late in life Musculoskeletal presentation (NKCC1 chl) Na-Cl channel in DT Salt wasting , hypokalemic metabolic alkalosis Hypomagnesemia, hypocalciuria Normotensive Increased renin , aldosterone Urine prostaglandin E normal
Pseudohypoaldosteronism Type 2 features
AD inheritance, HTN -2-3rd decade NAGMA DCT: inhibition of ROMK->Hyperkalemia, stimulation of NCC -increased Na hypercalciuria High aldosterone levels Rx-thiazides
Absorption in cortical collecting duct
2 cell types-Principal cells(Na+K chls, water balance), intercalated cells (pH balance)
Sodium absorption via ENaC
ADH acting onV2 receptors - insertion of aquaporin ch
Aldosterone receptor -increases Na channels
ANP binds - decrease Na channels
Li enters via ENaC
Diuretics -Amiloride and triamterene act to close Na chl
Liddle syndrome
AD inheritance
Inability to catabolise ENaC -increased Na absorption
Early onset hypertension + hypokalemic metabolic alkalosis
Decreased renin and aldosterone
Rx- amiloride/ triamterene
Apparent mineralocorticoid excess/liquorice)
Deficiency of 11beta-HSD2 (required to convert cortisol to cortisone)
Excess cortisol -> increased mineralocorticoid activity
Indication of vasopressin receptor antagonists
SIADH
C/c hyponatremia when other Rx failed
S/E hepatotoxicity
Agents -tolvaptan, conivaptan
Causes of Type1 RTA
Autoimmune -SLE, sjogrens, RA
Hereditary hypercalciuria, hyperparathyroidism, Vit D intoxication
Thyroid disorders
Hypergammaglobulinemia, Sickle cell anemia
Drug- Amphotericin, Ifosphamide,NSAID,PPI, Li
Obstructive uropathy
Chronic hepatitis
Renal transplantation
Features of Type 2RTA
Failure of prox tubular HCO3 reabsorption
Milder acidosis than Type 1
Urine pH<5.5
Rx- high dose HCO3
Often associated with Fanconi’s syndrome
Confirmatory test -Frac excretion of HCO3>25%
Causes of Type 2 RTA
Drugs -Adefovir, tenofovir, aminoglycosides
Fanconi’s syndrome
Multiple myeloma, amyloidosis
Heavy metal poisoning
Interstitial nephritis -drugs, infections (CMV,lepto)